The HPV Vaccine Story.
作者信息
Frazer Ian H
机构信息
The University of Queensland, Brisbane, Queensland 4102, Australia.
出版信息
ACS Pharmacol Transl Sci. 2019 May 29;2(3):210-212. doi: 10.1021/acsptsci.9b00032. eCollection 2019 Jun 14.
Abstract
摘要
相似文献
1
The HPV Vaccine Story.人乳头瘤病毒疫苗的故事
ACS Pharmacol Transl Sci. 2019 May 29;2(3):210-212. doi: 10.1021/acsptsci.9b00032. eCollection 2019 Jun 14.
2
Stories about HPV vaccine in social media, traditional media, and conversations.社交媒体、传统媒体和对话中的 HPV 疫苗相关故事。
Prev Med. 2019 Jan;118:251-256. doi: 10.1016/j.ypmed.2018.11.005. Epub 2018 Nov 7.
3
Topics associated with conflict in print news coverage of the HPV vaccine during 2005 to 2009.2005年至2009年期间，印刷新闻报道中与HPV疫苗冲突相关的主题。
Hum Vaccin Immunother. 2014;10(12):3466-74. doi: 10.4161/21645515.2014.979622.
4
Australian newspaper coverage of human papillomavirus vaccination, October 2006-December 2009.澳大利亚报纸对人乳头瘤病毒疫苗接种的报道，2006 年 10 月至 2009 年 12 月。
J Health Commun. 2012;17(2):149-59. doi: 10.1080/10810730.2011.585700. Epub 2011 Dec 2.
5
[Nine-valent HPV vaccine - new generation of HPV vaccine].九价人乳头瘤病毒疫苗——新一代人乳头瘤病毒疫苗
Ceska Gynekol. 2015 Dec;80(6):397-400.
6
Understanding human papillomavirus vaccine uptake.理解人乳头瘤病毒疫苗接种率。
Vaccine. 2012 Nov 20;30 Suppl 5:F149-56. doi: 10.1016/j.vaccine.2012.04.107.
7
Clinical guideline for 9-valent HPV vaccine: Korean Society of Gynecologic Oncology Guideline.《九价人乳头瘤病毒疫苗临床应用指南：韩国妇科肿瘤学会指南》
J Gynecol Oncol. 2019 Mar;30(2):e31. doi: 10.3802/jgo.2019.30.e31. Epub 2019 Jan 9.
8
[Research progression of prophylactic HPV vaccine application].[预防性人乳头瘤病毒疫苗应用的研究进展]
Zhonghua Zhong Liu Za Zhi. 2018 Oct 23;40(10):724-728. doi: 10.3760/cma.j.issn.0253-3766.2018.10.002.
9
Age at HPV vaccine initiation and completion among US adolescent girls: trend from 2008 to 2012.美国青春期女孩开始和完成人乳头瘤病毒（HPV）疫苗接种的年龄：2008年至2012年的趋势
Vaccine. 2015 Jan 29;33(5):585-7. doi: 10.1016/j.vaccine.2014.12.021. Epub 2014 Dec 18.
10
Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents.10至15岁青少年父母对人乳头瘤病毒疫苗的接受度
J Low Genit Tract Dis. 2004 Jul;8(3):188-94. doi: 10.1097/00128360-200407000-00005.
引用本文的文献
1
HPV DNA screening and vaccination strategies in Tunisia.突尼斯的人乳头瘤病毒DNA筛查与疫苗接种策略
Sci Rep. 2025 Jul 31;15(1):27916. doi: 10.1038/s41598-025-13423-3.
2
Human Papilloma Virus (HPV)-Mediated Oropharyngeal Squamous Cell Carcinoma Incidence Relative to Geographic Rates of HPV Vaccination in the United States.人乳头瘤病毒（HPV）介导的口咽鳞状细胞癌发病率与美国HPV疫苗接种的地理速率的相关性
Cureus. 2025 Mar 30;17(3):e81459. doi: 10.7759/cureus.81459. eCollection 2025 Mar.
3
The Global Fund, Cervical Cancer, and HPV infections: what can low- and middle-income countries do to accelerate progress by 2030?全球基金、宫颈癌与人乳头瘤病毒感染：低收入和中等收入国家如何在2030年前加速进展？
EClinicalMedicine. 2025 Feb 21;81:103127. doi: 10.1016/j.eclinm.2025.103127. eCollection 2025 Mar.
4
Translational Gynecologic Oncology at Midlife and Beyond: A Difficult Bedside to Community Transition.中年及以后的转化性妇科肿瘤学：从病床边到社区的艰难过渡。
J Midlife Health. 2024 Oct-Dec;15(4):225-227. doi: 10.4103/jmh.jmh_193_24. Epub 2025 Jan 2.
5
A Novel Polymersome Nanocarrier Promotes Anti-Tumour Immunity by Improved Priming of CD8 T Cells.一种新型聚合物囊泡纳米载体通过改善CD8⁺ T细胞的启动来促进抗肿瘤免疫。
Immunology. 2025 May;175(1):21-35. doi: 10.1111/imm.13903. Epub 2025 Jan 28.
6
Virus-like particle: a nano-platform that delivers cancer antigens to elicit an anti-tumor immune response.病毒样颗粒：一种递送癌症抗原以引发抗肿瘤免疫反应的纳米平台。
Front Immunol. 2025 Jan 7;15:1504124. doi: 10.3389/fimmu.2024.1504124. eCollection 2024.
7
Targeting HPV for the prevention, diagnosis, and treatment of cervical cancer.针对人乳头瘤病毒（HPV）进行宫颈癌的预防、诊断和治疗。
J Mol Cell Biol. 2025 May 2;16(10). doi: 10.1093/jmcb/mjae046.
8
Therapeutic Strategies in Advanced Cervical Cancer Detection, Prevention and Treatment.晚期宫颈癌的检测、预防与治疗中的治疗策略
Onco Targets Ther. 2024 Sep 25;17:785-801. doi: 10.2147/OTT.S475132. eCollection 2024.
9
Lipid Nanoparticles Outperform Electroporation in Delivering Therapeutic HPV DNA Vaccines.脂质纳米颗粒在递送治疗性人乳头瘤病毒DNA疫苗方面优于电穿孔法。
Vaccines (Basel). 2024 Jun 17;12(6):666. doi: 10.3390/vaccines12060666.
10
Editorial: HPV natural history, immunological responses and vaccination strategies: challenges and opportunities.社论：人乳头瘤病毒的自然史、免疫反应及疫苗接种策略：挑战与机遇
Front Immunol. 2024 Jan 8;14:1349664. doi: 10.3389/fimmu.2023.1349664. eCollection 2023.
本文引用的文献
1
The projected timeframe until cervical cancer elimination in Australia: a modelling study.澳大利亚消除宫颈癌的预计时间框架：建模研究。
Lancet Public Health. 2019 Jan;4(1):e19-e27. doi: 10.1016/S2468-2667(18)30183-X. Epub 2018 Oct 2.
2
No Vacillation on HPV Vaccination.坚决接种 HPV 疫苗。
Cell. 2018 Mar 8;172(6):1163-1167. doi: 10.1016/j.cell.2018.02.045.
3
A vaccine to prevent cervical cancer: academic and industrial collaboration and a Lasker award.一种预防宫颈癌的疫苗：学术与产业合作及拉斯克奖
Clin Transl Immunology. 2017 Dec 28;7(1):e1002. doi: 10.1002/cti2.1002. eCollection 2018.
4
University contributions to the HPV vaccine and implications for access to vaccines in developing countries: addressing materials and know-how in university technology transfer policy.大学对人乳头瘤病毒疫苗的贡献及对发展中国家疫苗可及性的影响：在大学技术转让政策中解决材料和技术诀窍问题
Am J Law Med. 2009;35(2-3):253-79. doi: 10.1177/009885880903500202.
5
Finding a vaccine for human papillomavirus.寻找人乳头瘤病毒疫苗。
Lancet. 2006 Jun 24;367(9528):2058-9. doi: 10.1016/S0140-6736(06)68921-6.
6
A controlled trial of a human papillomavirus type 16 vaccine.一项16型人乳头瘤病毒疫苗的对照试验。
N Engl J Med. 2002 Nov 21;347(21):1645-51. doi: 10.1056/NEJMoa020586.
7
Synthesis and assembly of infectious bovine papillomavirus particles in vitro.传染性牛乳头瘤病毒颗粒的体外合成与组装
J Gen Virol. 1993 Apr;74 ( Pt 4):763-8. doi: 10.1099/0022-1317-74-4-763.
8
Tumorigenicity by human papillomavirus type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell growth and differentiation.人乳头瘤病毒16型E6和E7在转基因小鼠中的致瘤性与上皮细胞生长和分化的改变相关。
J Virol. 1993 Mar;67(3):1373-84. doi: 10.1128/JVI.67.3.1373-1384.1993.
9
Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles.人乳头瘤病毒16型L1和L1-L2高效自组装成病毒样颗粒。
J Virol. 1993 Dec;67(12):6929-36. doi: 10.1128/JVI.67.12.6929-6936.1993.
10
A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer.一种新型乳头瘤病毒DNA，其在生殖器癌活检组织及源自宫颈癌的细胞系中的存在情况。
EMBO J. 1984 May;3(5):1151-7. doi: 10.1002/j.1460-2075.1984.tb01944.x.
Zotero 插件